Cargando…
An Epigenetic Signature in Peripheral Blood Associated with the Haplotype on 17q21.31, a Risk Factor for Neurodegenerative Tauopathy
Little is known about how changes in DNA methylation mediate risk for human diseases including dementia. Analysis of genome-wide methylation patterns in patients with two forms of tau-related dementia – progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD) – revealed significant dif...
Autores principales: | Li, Yun, Chen, Jason A., Sears, Renee L., Gao, Fuying, Klein, Eric D., Karydas, Anna, Geschwind, Michael D., Rosen, Howard J., Boxer, Adam L., Guo, Weilong, Pellegrini, Matteo, Horvath, Steve, Miller, Bruce L., Geschwind, Daniel H., Coppola, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945475/ https://www.ncbi.nlm.nih.gov/pubmed/24603599 http://dx.doi.org/10.1371/journal.pgen.1004211 |
Ejemplares similares
-
The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk
por: Harerimana, Nadia V., et al.
Publicado: (2022) -
Genetic Flux Between H1 and H2 Haplotypes of the 17q21.31 Inversion in European Population
por: Deng, Libin, et al.
Publicado: (2011) -
Neolithic expansion and the 17q21.31 inversion in Iberia: an evolutionary approach to H2 haplotype distribution in the Near East and Europe
por: Espinosa, Ibone, et al.
Publicado: (2022) -
Structural Diversity and African Origin of the 17q21.31 Inversion Polymorphism
por: Steinberg, Karyn Meltz, et al.
Publicado: (2012) -
17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytes
por: Bowles, Kathryn R., et al.
Publicado: (2022)